Published in Law and Health Weekly, March 31st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Cepheid.
Report 1: Cepheid (CPHD) and Idaho Technology, Inc. announced that they have entered into a settlement and cross-license agreement to resolve a dispute related to Idaho Technology and Cepheid intellectual property in rapid polymerase chain reaction methods and instrumentation, the use of SYBR Green I in PCR reactions, and certain methods of analysis of real-time PCR data.
The settlement agreement resolves all claims asserted in the United States District Court for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.